Syzygium Jambos Seed

Generic Name: syzygium jambos seed

Over-the-Counter (OTC)

Brand Names:

Eugenia Jambosa

Uses: See symptoms on front panel. Relieves blackheads associated with menstruation *

Overview

Uses: See symptoms on front panel. Relieves blackheads associated with menstruation *

Uses

Uses: See symptoms on front panel. Relieves blackheads associated with menstruation *

Dosage

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Side Effects

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.

Pregnancy

If pregnant or breast-feeding, ask a health professional before use.

Frequently Asked Questions

What is Syzygium Jambos Seed used for?▼

Uses: See symptoms on front panel. Relieves blackheads associated with menstruation *

What are the side effects of Syzygium Jambos Seed?▼

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.

Can I take Syzygium Jambos Seed during pregnancy?▼

If pregnant or breast-feeding, ask a health professional before use.

Related Medications

Avi-4658 250l

avi-4658 250l

Dosage form: POWDER. Active ingredients: ETEPLIRSEN (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

11 DESCRIPTION Ixazomib is a proteasome inhibitor. Ixazomib citrate, a prodrug, rapidly hydrolyzes under physiological conditions to its biologically active form, ixazomib. The chemical name of ixazomib citrate is 1,3,2-dioxaborolane-4,4-diacetic acid, 2-[(1 R )-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo- and the structural formula is: The molecular formula for ixazomib citrate is C 20 H 23 BCl 2 N 2 O 9 and its molecular weight is 517.12.

Plozasiran

plozasiran

APOC-III-directed RNA Interaction [EPC]

11 DESCRIPTION REDEMPLO contains plozasiran (present as plozasiran sodium), a small interfering RNA (siRNA) that degrades apolipoprotein C-III ( apoC-III ) mRNA by RNA interference. Plozasiran contains a covalently linked ligand containing three N-acetylgalactosamine (GalNAc) residues to facilitate delivery to hepatocytes. The 2´ positions of the ribose subunits in plozasiran are modified with either fluorine (2´F) or methoxy (2´O-Me) groups.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.